Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Zenith Updates

Toinv

Jan 29, 2016 10:52AM

Jan 29, 2016 12:50PM

Jan 30, 2016 10:49AM

Jan 30, 2016 11:14AM

Jan 30, 2016 01:05PM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Updates

posted on Feb 02, 2016 02:53PM

Google searches often turn up some unexpected tidbits. For example, I just found this blog entry on the Seton Hall University Department of Biology page discussing "BET Bromodomain Inhibition in Prostate Cancer Treatment" and highlighting ZEN-3694 and their upcoming trial.

Also, Zenith has updated their homepage and events page to reflect the H1 2016 anticipated start date and some spring events.

BearDownAZ

7 Recommendations

Re: Zenith Updates

masila

Feb 02, 2016 07:02PM

Feb 02, 2016 07:40PM

Feb 02, 2016 10:41PM